GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 745 filers reported holding GLAXOSMITHKLINE PLC in Q3 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $293,000 | +5.8% | 6,687 | +5.8% | 0.00% | – |
| Q1 2022 | $277,000 | +154.1% | 6,320 | +27.7% | 0.00% | – |
| Q4 2021 | $109,000 | +21.1% | 4,949 | +4.3% | 0.00% | – |
| Q3 2021 | $90,000 | -6.2% | 4,744 | +96.1% | 0.00% | – |
| Q2 2021 | $96,000 | -44.5% | 2,419 | -49.9% | 0.00% | – |
| Q1 2021 | $173,000 | -51.4% | 4,831 | -50.0% | 0.00% | – |
| Q4 2020 | $356,000 | +96.7% | 9,662 | +100.0% | 0.00% | – |
| Q3 2020 | $181,000 | -8.6% | 4,831 | 0.0% | 0.00% | – |
| Q2 2020 | $198,000 | +2.1% | 4,831 | -5.5% | 0.00% | – |
| Q1 2020 | $194,000 | -18.8% | 5,111 | 0.0% | 0.00% | – |
| Q4 2019 | $239,000 | +3.0% | 5,111 | -6.8% | 0.00% | – |
| Q3 2019 | $232,000 | +66.9% | 5,485 | +57.6% | 0.00% | – |
| Q2 2019 | $139,000 | -16.3% | 3,480 | -12.6% | 0.00% | – |
| Q1 2019 | $166,000 | -1.2% | 3,980 | -9.5% | 0.00% | – |
| Q4 2018 | $168,000 | -5.1% | 4,399 | +0.3% | 0.00% | – |
| Q3 2018 | $177,000 | +24.6% | 4,385 | +21.8% | 0.00% | – |
| Q2 2018 | $142,000 | +0.7% | 3,600 | 0.0% | 0.00% | – |
| Q1 2018 | $141,000 | +10.2% | 3,600 | 0.0% | 0.00% | – |
| Q4 2017 | $128,000 | -11.7% | 3,600 | 0.0% | 0.00% | – |
| Q3 2017 | $145,000 | -7.1% | 3,600 | 0.0% | 0.00% | – |
| Q2 2017 | $156,000 | -49.0% | 3,600 | -50.0% | 0.00% | – |
| Q1 2017 | $306,000 | +120.1% | 7,200 | +100.0% | 0.00% | – |
| Q4 2016 | $139,000 | -17.3% | 3,600 | -7.9% | 0.00% | – |
| Q3 2016 | $168,000 | -6.7% | 3,908 | -6.1% | 0.00% | – |
| Q2 2016 | $180,000 | +5.9% | 4,164 | 0.0% | 0.00% | – |
| Q1 2016 | $170,000 | +17.2% | 4,164 | +15.7% | 0.00% | – |
| Q4 2015 | $145,000 | +5.1% | 3,600 | 0.0% | 0.00% | – |
| Q3 2015 | $138,000 | -8.6% | 3,600 | 0.0% | 0.00% | – |
| Q2 2015 | $151,000 | -10.7% | 3,600 | 0.0% | 0.00% | – |
| Q1 2015 | $169,000 | +9.7% | 3,600 | 0.0% | 0.00% | – |
| Q4 2014 | $154,000 | -99.9% | 3,600 | 0.0% | 0.00% | – |
| Q3 2014 | $165,492,000 | -42.7% | 3,600 | -33.3% | 0.00% | – |
| Q2 2014 | $288,792,000 | -48.0% | 5,400 | -48.1% | 0.00% | -100.0% |
| Q1 2014 | $555,672,000 | +21.0% | 10,400 | +20.9% | 0.00% | 0.0% |
| Q4 2013 | $459,154,000 | +6.4% | 8,600 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $431,462,000 | – | 8,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |